RRM1 inhibition sensitizes lung adenocarcinoma to decitabine treatment. - Jiang N; Liu J; Vaghasia A; Anders N; Rudek M; Nelson WG; Yegnasubramanian S; Zhou J (Cell death & disease, 2026)